These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16100966)

  • 1. Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.
    Silveira-Moriyama L; Gonçalves LR; Chien HF; Barbosa ER
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):221-4. PubMed ID: 16100966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
    Barbosa ER; Takada LT; Gonçalves LR; Costa RM; Silveira-Moriyama L; Chien HF
    Arq Neuropsiquiatr; 2010 Aug; 68(4):502-5. PubMed ID: 20730300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blepharospasm with non-satisfactory response to treatment: our experience with IncobotulinumtoxinA.
    Ricciardi L; Ialongo T; Guidubaldi A; Di Giacopo R; Bentivoglio AR
    Parkinsonism Relat Disord; 2014 Jun; 20(6):665-7. PubMed ID: 24685658
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
    Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
    Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.
    Wabbels B; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):45-50. PubMed ID: 16874524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported benefit from botulinum toxin treatment for essential blepharospasm: using 2 assessment scales.
    Lee RM; Chowdhury HR; Hyer JN; Smith HB; Jones CA
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):196-7. PubMed ID: 23446304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm.
    Fezza J; Burns J; Woodward J; Truong D; Hedges T; Verma A
    J Neurol Sci; 2016 Aug; 367():56-62. PubMed ID: 27423565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting botulinum toxin into the treatment of blepharospasm.
    Popescu MN; Popescu SI; Cernat CC; Boariu AM; Călin E; Vieru A; Muşat O
    Rom J Ophthalmol; 2018; 62(2):162-165. PubMed ID: 30206561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
    Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
    Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
    Lee S; Park S; Lew H
    Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated.
    Batisti JP; Kleinfelder AD; Galli NB; Moro A; Munhoz RP; Teive HA
    Arq Neuropsiquiatr; 2017 Feb; 75(2):87-91. PubMed ID: 28226076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A therapy for blepharospasm.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.